Global distribution MPA Pharma operates a group with manufacturing and multiple distributors across German-speaking and Nordic regions, indicating a broad network for cross-border parallel imports and potential cross-sell of compliant supply services and contract manufacturing to adjacent markets.

Quality and compliance As an authorised manufacturer adhering to GMP, GDP, national and EU regulatory standards, MPA Pharma presents a credible partner for high-quality supply, QA services, and potential expansion of regulated procurement or contract manufacturing partnerships.

Reimport & trading Core focus on EU medicinal product reimport and parallel import creates opportunities to offer additional sourcing, logistics optimization, and regulatory consulting to optimize cross-country procurement and distribution for pharma buyers.

Mid-market growth With revenue in the tens of millions and a mid-size employee base, there is room to expand sales via enhanced contract manufacturing capacity, increased product portfolio via strategic partnerships, and targeted outreach to regional distributors.

Tech-enabled ops Existing tech stack (iCIMS, Adobe, ERP/office tools) suggests potential to streamline partner onboarding, CRM-driven account penetration, and digital marketing to attract new distributors and manufacturers seeking compliant supply partners.